Non-alcoholic fatty liver disease (NAFLD) and the quest for effective treatments

Kessarin Thanapirom^{1

2}, Emmanuel A Tsochatzis¹

Affiliations

¹ UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK.
² Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.

Editorial

Kessarin Thanapirom et al. Hepatobiliary Surg Nutr. 2019 Feb.

. 2019 Feb;8(1):77-79.

doi: 10.21037/hbsn.2018.11.06.

Kessarin Thanapirom^{1

2}, Emmanuel A Tsochatzis¹

¹ UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK.
² Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Mechanisms of NAFLD development and therapeutic strategies.
Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Friedman SL, et al. Nat Med. 2018 Jul;24(7):908-922. doi: 10.1038/s41591-018-0104-9. Epub 2018 Jul 2. Nat Med. 2018. PMID: 29967350 Free PMC article. Review.

1. Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018;15:11-20. 10.1038/nrgastro.2017.109 - DOI - PubMed
1. Adams LA, Anstee QM, Tilg H, et al. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017;66:1138-53. 10.1136/gutjnl-2017-313884 - DOI - PubMed
1. Tsochatzis E, Coilly A, Nadalin S, et al. International Liver Transplantation Consensus Statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation. Transplantation 2019;103:45-56. 10.1097/TP.0000000000002433 - DOI - PubMed
1. Goldberg D, Ditah IC, Saeian K, et al. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. Gastroenterology 2017;152:1090-9.e1. 10.1053/j.gastro.2017.01.003 - DOI - PMC - PubMed
1. Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of NAFLD development and therapeutic strategies. Nat Med 2018;24:908-22. 10.1038/s41591-018-0104-9 - DOI - PMC - PubMed